Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03592914 · ClinicalTrials.gov registry record
Respiratory Rate Accuracy Verification Clinical: Pulmonary Rehabilitation Patients
A clinical trial, sponsored by Nonin Medical.
- Completed
- Registry status
- 60
- Enrollment target
NCT03592914: Completed study, sponsored by Nonin Medical.
NCT03592914 is a clinical trial that has completed, run by Nonin Medical. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03592914 has completed, sponsored by Nonin Medical.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Study Design: This study is a comparative, single-center study. This is a minimal risk study (as defined in 21 CFR Part 56) using a non-significant risk device (as defined in 21 CFR Part 812.3). A minimum of 60 subjects will be enrolled in the study. Subject participation will last approximately 1 hour.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2019-01-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03592914
The ClinicalTrials.gov registry entry for NCT03592914 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nonin Medical, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03592914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03592914 about?
NCT03592914 is a clinical study titled "Respiratory Rate Accuracy Verification Clinical: Pulmonary Rehabilitation Patients". Study Design: This study is a comparative, single-center study. This is a minimal risk study (as defined in 21 CFR Part 56) using a non-significant risk device (as defined in 21 CFR Part 812.3). A minimum of 60 subjects will be enrolled in the study. Subject participation will last approximately 1 h...
What is the current status of trial NCT03592914?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2018-07-31. Estimated completion is 2019-01-16.
Who is sponsoring clinical trial NCT03592914?
This trial is sponsored by Nonin Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.